drugset / Trial / NCT02792647
A Study of Multiple Oral Doses of IX-01 in Healthy Male Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety and tolerability of IX-01 after multiple doses, and to determine the PK of IX-01 and activity of CYP3A4.
Timeline
- Start
- 2016-05
- Primary completion
- 2016-07
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IX-01 | Unknown | 1600 mg | Oral |
| Subject | IX-01 | Unknown | 2400 mg | Oral |
Indications
No indication recorded.